145 related articles for article (PubMed ID: 12837522)
1. The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study.
Messamore E; Hoffman WF; Janowsky A
Schizophr Res; 2003 Aug; 62(3):251-8. PubMed ID: 12837522
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
Messamore E
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):413-9. PubMed ID: 14623495
[TBL] [Abstract][Full Text] [Related]
3. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Messamore E; Hoffman WF; Yao JK
Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
[TBL] [Abstract][Full Text] [Related]
4. Niacin subsensitivity is associated with functional impairment in schizophrenia.
Messamore E
Schizophr Res; 2012 May; 137(1-3):180-4. PubMed ID: 22445461
[TBL] [Abstract][Full Text] [Related]
5. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
Ross BM; Hughes B; Turenne S; Seeman M; Warsh JJ
Eur Neuropsychopharmacol; 2004 May; 14(3):191-7. PubMed ID: 15056478
[TBL] [Abstract][Full Text] [Related]
6. Niacin skin flush in schizophrenia: a preliminary report.
Ward PE; Sutherland J; Glen EM; Glen AI
Schizophr Res; 1998 Feb; 29(3):269-74. PubMed ID: 9516668
[TBL] [Abstract][Full Text] [Related]
7. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
8. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
Smesny S; Rosburg T; Riemann S; Baur K; Rudolph N; Berger G; Sauer H
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
[TBL] [Abstract][Full Text] [Related]
9. Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: A preliminary investigation.
Ross BM
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():99-102. PubMed ID: 28552466
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
Smesny S; Rosburg T; Baur K; Rudolph N; Sauer H
Neuropsychopharmacology; 2007 Oct; 32(10):2067-73. PubMed ID: 17314920
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.
Yao JK; Dougherty GG; Gautier CH; Haas GL; Condray R; Kasckow JW; Kisslinger BL; Gurklis JA; Messamore E
Schizophr Bull; 2016 Mar; 42(2):369-76. PubMed ID: 26371338
[TBL] [Abstract][Full Text] [Related]
12. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
14. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
Morrow JD; Awad JA; Oates JA; Roberts LJ
J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
[TBL] [Abstract][Full Text] [Related]
15. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
Nilsson BM; Hultman CM; Wiesel FA
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
[TBL] [Abstract][Full Text] [Related]
16. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
Smesny S; Klemm S; Stockebrand M; Grunwald S; Gerhard UJ; Rosburg T; Sauer H; Blanz B
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
[TBL] [Abstract][Full Text] [Related]
17. An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia.
Nadalin S; Jonovska S; Šendula Jengić V; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102084. PubMed ID: 32126479
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans.
Holowatz LA; Kenney WL
J Physiol; 2007 Jun; 581(Pt 2):863-72. PubMed ID: 17347269
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients.
Nadalin S; Radović I; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2015 Sep; 100():29-32. PubMed ID: 26160611
[TBL] [Abstract][Full Text] [Related]
20. Niacin skin flush is not diagnostic of schizophrenia.
Wilson DW; Douglass AB
Biol Psychiatry; 1986 Aug; 21(10):974-7. PubMed ID: 3741914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
